EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
出版年份 2020 全文链接
标题
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
作者
关键词
Review, Epidermal growth factor receptor (EGFR), Immunoconjugates, Nanoparticles, Drug delivery, Cancer
出版物
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 592, Issue -, Pages 120082
出版商
Elsevier BV
发表日期
2020-11-12
DOI
10.1016/j.ijpharm.2020.120082
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity
- (2020) Loujin Houdaihed et al. PHARMACEUTICAL RESEARCH
- Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
- (2020) Raquel B. Liszbinski et al. Materials
- Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation
- (2020) Sylwia Jones et al. Scientific Reports
- Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC
- (2020) Iosune Baraibar et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles
- (2020) Raquel Petrilli et al. CURRENT MEDICINAL CHEMISTRY
- Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives
- (2020) Seyed Hossein Kiaie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
- (2020) A.C. Marques et al. JOURNAL OF CONTROLLED RELEASE
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
- (2020) Adileh Ayati et al. BIOORGANIC CHEMISTRY
- Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation
- (2020) Siddharth Adityan et al. JOURNAL OF CONTROLLED RELEASE
- Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck
- (2020) Yi-Ping Wang et al. ORAL ONCOLOGY
- Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
- (2019) Seyed Mohammadali Dadfar et al. ADVANCED DRUG DELIVERY REVIEWS
- Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer
- (2019) Qinlu Zhang et al. JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
- Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR
- (2019) Nadja Groysbeck et al. NANOTECHNOLOGY
- Synthesis and physicochemical characterization of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as a novel targeting cancer detection
- (2019) Daryoush Shahbazi-Gahrouei et al. IET Nanobiotechnology
- Composition design and medical application of liposomes
- (2019) Mingyuan Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer
- (2019) Xiaoyan Lu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
- (2019) Mark Rosenthal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TARGETING EGFR PATHWAY IN METASTATIC COLORECTAL CANCER- TUMOUR HETEROGENIETY AND CONVERGENT EVOLUTION
- (2019) Khurum Khan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor targeting peptides: novel therapeutic strategies in glioblastoma
- (2019) Drazen Raucher CURRENT OPINION IN PHARMACOLOGY
- Fluorescein- and EGFR-Antibody Conjugated Silica Nanoparticles for Enhancement of Real-time Tumor Border Definition Using Confocal Laser Endomicroscopy in Squamous Cell Carcinoma of the Head and Neck
- (2019) Anna Watermann et al. Nanomaterials
- Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin
- (2019) Shenghu Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Iron oxide nanoparticles for therapeutic applications
- (2019) Edouard Alphandéry DRUG DISCOVERY TODAY
- EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers
- (2019) Lucyna Matusewicz et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anti-EGFR antibody conjugated thiol chitosan-layered gold nanoshells for dual-modal imaging-guided cancer combination therapy
- (2019) Panchanathan Manivasagan et al. JOURNAL OF CONTROLLED RELEASE
- INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma
- (2019) Martin van den Bent et al. NEURO-ONCOLOGY
- The physicochemical and biological characterization of a 24-month-stored nanocomplex based on gold nanoparticles conjugated with cetuximab demonstrated long-term stability, EGFR affinity and cancer cell death due to apoptosis
- (2019) Lidia M. Andrade et al. Materials Science & Engineering C-Materials for Biological Applications
- A Third Shot at EGFR: New Opportunities in Cancer Therapy
- (2019) Salvador Guardiola et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanostructured lipid carriers for site-specific drug delivery
- (2018) Archana Khosa et al. BIOMEDICINE & PHARMACOTHERAPY
- Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
- (2018) Glenwood D. Goss et al. CANCER
- Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin
- (2018) Diana Rafael et al. CHEMICAL ENGINEERING JOURNAL
- A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial
- (2018) Gilberto de Castro Junior et al. EUROPEAN JOURNAL OF CANCER
- Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection
- (2018) Raquel Petrilli et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells
- (2018) Jitendrakumar Patel et al. JOURNAL OF MICROENCAPSULATION
- Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
- (2018) Andrew C. Phillips et al. MOLECULAR CANCER THERAPEUTICS
- Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies
- (2018) Xiuhua Kang et al. MEDICAL SCIENCE MONITOR
- Enhanced Antitumor Effects of Epidermal Growth Factor Receptor Targetable Cetuximab-Conjugated Polymeric Micelles for Photodynamic Therapy
- (2018) Ming-Hsiang Chang et al. Nanomaterials
- Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer
- (2018) Konstantina Kyriakopoulou et al. CELLULAR SIGNALLING
- Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
- (2018) Naresh Goli et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- SYNTHESIS AND CHARACTERIZATION OF CETUXIMAB-DOCETAXEL AND PANITUMUMAB-DOCETAXEL ANTIBODY-DRUG CONJUGATES FOR EGFR-OVEREXPRESSING CANCER THERAPY
- (2018) Dylan M Glatt et al. MOLECULAR PHARMACEUTICS
- Necitumumab for the treatment of advanced non-small-cell lung cancer
- (2018) Asunción Díaz-Serrano et al. Future Oncology
- An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies
- (2018) Xin-yue Hu et al. Molecular Oncology
- Development of a novel thermal-sensitive multifunctional liposome with antibody conjugation to target EGFR-expressing tumors
- (2018) Kuan-Chieh Liu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer
- (2018) Jeffrey R. Ashton et al. PLoS One
- Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer
- (2017) Naoko Matsuda et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers
- (2017) Wei-Wei Xu et al. International Journal of Nanomedicine
- EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer
- (2017) Ying-Hsia Shih et al. JOURNAL OF CONTROLLED RELEASE
- Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer
- (2017) Meihua Zhang et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy
- (2017) Jia-kang Wang et al. Materials Science & Engineering C-Materials for Biological Applications
- EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer
- (2017) Goutam Mondal et al. MOLECULAR PHARMACEUTICS
- Anti-EGFR antibody conjugated silica nanoparticles as probes for lung cancer detection
- (2017) Jun Wan et al. Experimental and Therapeutic Medicine
- Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
- (2017) Muhammad Kalim et al. Drug Design Development and Therapy
- Improved bioavailability of curcumin in liposomes prepared using a pH-driven, organic solvent-free, easily scalable process
- (2017) Ce Cheng et al. RSC Advances
- Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”
- (2017) Endang Purba et al. Cells
- Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells
- (2016) Josimar Eloy et al. Anti-Cancer Agents in Medicinal Chemistry
- EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery
- (2016) Azadeh Haeri et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy
- (2016) Josimar O. Eloy et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy
- (2016) Yung-Chih Kuo et al. LIFE SCIENCES
- Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)
- (2016) Martin Reck et al. Oncology Research and Treatment
- Detection and Imaging of Aggressive Cancer Cells Using an Epidermal Growth Factor Receptor (EGFR)-Targeted Filamentous Plant Virus-Based Nanoparticle
- (2015) Paul L. Chariou et al. BIOCONJUGATE CHEMISTRY
- Activation of transmembrane cell-surface receptors via a common mechanism? The “rotation model”
- (2015) Ichiro N. Maruyama BIOESSAYS
- Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
- (2015) Gaurav Joshi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Antibody-targeted drugs and drug resistance—Challenges and solutions
- (2015) LeeRon Shefet-Carasso et al. DRUG RESISTANCE UPDATES
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial
- (2015) Andreas Wicki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells
- (2015) Yanuar Dwi Putra Limasale et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer
- (2015) Sara Zalba et al. JOURNAL OF CONTROLLED RELEASE
- AMG 595, an Anti-EGFRvIII Antibody-Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma
- (2015) K. J. Hamblett et al. MOLECULAR CANCER THERAPEUTICS
- Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
- (2015) R. Dienstmann et al. Cancer Discovery
- Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
- (2015) Milota Kaluzova et al. Oncotarget
- Anti-EGFR-Conjugated Hollow Gold Nanospheres Enhance Radiocytotoxic Targeting of Cervical Cancer at Megavoltage Radiation Energies
- (2015) Jiao Liu et al. Nanoscale Research Letters
- Monoclonal Antibody–Conjugated Superparamagnetic Iron Oxide Nanoparticles for Imaging of Epidermal Growth Factor Receptor–Targeted Cells and Gliomas
- (2015) Ketao Mu et al. Molecular Imaging
- Mechanisms of resistance to EGFR tyrosine kinase inhibitors
- (2015) Lihua Huang et al. Acta Pharmaceutica Sinica B
- Cisplatin–alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells
- (2014) Yunfei Wang et al. BIOMATERIALS
- Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery
- (2014) Josimar Oliveira Eloy et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer
- (2014) Stephen Goodall et al. JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
- Simple and efficient capture of EGFR-expressing tumor cells using magnetic nanoparticles
- (2014) Seong-Min Jo et al. SENSORS AND ACTUATORS B-CHEMICAL
- Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model
- (2013) Hao-Wen Kao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
- (2012) J. T. Hartmann et al. INVESTIGATIONAL NEW DRUGS
- Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas
- (2012) Tanja Trarbach et al. INVESTIGATIONAL NEW DRUGS
- Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
- (2012) Christoph Mamot et al. JOURNAL OF DRUG TARGETING
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptor
- (2011) Maria Leonor Alvarenga et al. ANALYTICAL BIOCHEMISTRY
- Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor
- (2011) Yung-Chih Kuo et al. BIOMATERIALS
- The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes
- (2011) Jie Gao et al. BIOMATERIALS
- EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma
- (2011) Jie Gao et al. BIOMATERIALS
- EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
- (2011) Sahil Aggarwal et al. Journal of Biomedical Nanotechnology
- Nimotuzumab and Cetuximab Block Ligand-independent EGF Receptor Signaling Efficiently at Different Concentrations
- (2011) Christian Berger et al. JOURNAL OF IMMUNOTHERAPY
- Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study
- (2010) S. Rao et al. ANNALS OF ONCOLOGY
- Characterization and Cancer Cell Specific Binding Properties of Anti-EGFR Antibody Conjugated Quantum Dots
- (2010) Junghan Lee et al. BIOCONJUGATE CHEMISTRY
- Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck
- (2010) Marta Osorio Rodríguez et al. CANCER BIOLOGY & THERAPY
- Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging
- (2010) Young-Seok Cho et al. CANCER LETTERS
- A novel hybrid peptide targeting EGFR-expressing cancers
- (2010) Masayuki Kohno et al. EUROPEAN JOURNAL OF CANCER
- Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients
- (2010) Katayoun Derakhshandeh International Journal of Nanomedicine
- Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor
- (2010) Arehalli S. Manjappa et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His
- (2009) Bin Feng et al. BIOMATERIALS
- Homo-FRET Imaging Enables Quantification of Protein Cluster Sizes with Subcellular Resolution
- (2009) Arjen N. Bader et al. BIOPHYSICAL JOURNAL
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
- (2009) A. Talavera et al. CANCER RESEARCH
- Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
- (2009) A. G. Polson et al. CANCER RESEARCH
- Integration of panitumumab into the treatment of colorectal cancer
- (2009) Cristina Gravalos et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab
- (2009) Javier Rodríguez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice
- (2009) In-Young Kim et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- The biological properties of cetuximab
- (2008) Bruno Vincenzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
- (2008) Kirstine Roepstorff et al. HISTOCHEMISTRY AND CELL BIOLOGY
- All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
- (2008) R.-H. Tao et al. JOURNAL OF CELL SCIENCE
- Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab
- (2007) Fernando Rivera et al. ACTA ONCOLOGICA
- Molecular contrast of EGFR expression using gold nanoparticles as a reflectance-based imaging probe
- (2007) J.C.Y. Kah et al. MOLECULAR AND CELLULAR PROBES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now